LP-533401
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


LP-533401
Description :
LP-533401 is a Tryptophan hydroxylase 1 inhibitor that regulates serotonin production in the gut.UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Tryptophan HydroxylaseType :
Reference compoundRelated Pathways :
Metabolic Enzyme/ProteaseApplications :
COVID-19-immunoregulationField of Research :
Metabolic Disease; Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/LP-533401.htmlConcentration :
10mMPurity :
99.02Solubility :
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
N[C@@H](CC1=CC=C(C2=NC(N)=NC(OC(C3=CC=C(C4=CC=CC(F)=C4)C=C3)C(F)(F)F)=C2)C=C1)C(O)=OMolecular Formula :
C27H22F4N4O3Molecular Weight :
526.48Precautions :
H302, H315, H319, H335References & Citations :
[1]Yadav, V.K., et al. Inhibition of gut-derived serotonin synthesis: A potential bone anabolic treatment. Nat. Med. 16 (3), 308-312 (2010) .|[2]Abid S, et al. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol. 2012 Sep 15;303 (6) :L500-8.|[3]Krevvata M, et al. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood. 2014 Oct 30;124 (18) :2834-46.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedCitation 01 :
Cell Signal. 2023 May:105:110612.|iMetaOmics. 2024 Oct 14.|iScience. 2025 Nov 18.|Life Sci. 2021 Nov 15:285:120002.|Nat Aging. 2024 Feb 6.|Nat Aging. 2024 Mar;4 (3) :414-433.CAS Number :
[945976-43-2]

